Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-16 Sale |
2023-08-18 4:03 pm |
Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer |
311,297 | $8.25 | $2,568,200 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-16 Exercise |
2023-08-18 4:03 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer |
311,297 | $3.72 | 0 (Direct) |
View |
| 2023-08-16 Exercise |
2023-08-18 4:03 pm |
N/A 2029-09-16 |
Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer |
311,297 | $0 | 0 (Direct) |
View |
| 2023-08-17 Gift |
2023-08-18 4:03 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
63,000 | $0 | 511,704 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-22 8:15 pm |
2024-06-21 2033-06-20 |
Foghorn Therapeutics Inc. | FHTX | PARSHALL B LYNNE Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-22 8:14 pm |
2024-06-21 2033-06-20 |
Foghorn Therapeutics Inc. | FHTX | Lynch Thomas J. Jr. Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-22 8:14 pm |
2024-06-21 2033-06-20 |
Foghorn Therapeutics Inc. | FHTX | Cole Douglas G. Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-22 8:13 pm |
2024-06-21 2033-06-20 |
Foghorn Therapeutics Inc. | FHTX | SMITH IAN F Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-22 8:13 pm |
2024-06-21 2033-06-20 |
Foghorn Therapeutics Inc. | FHTX | Biller Scott Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-22 8:12 pm |
2024-06-21 2033-06-20 |
Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-22 8:11 pm |
2024-06-21 2033-06-20 |
Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-22 8:10 pm |
2024-06-21 2033-06-20 |
Foghorn Therapeutics Inc. | FHTX | Mendelsohn Michael Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-05-26 Gift |
2023-05-31 9:22 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
300,000 | $0 | 448,704 (Indirect) |
View |
| 2022-10-25 Other |
2023-02-22 4:23 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
189,310 | $0 | 890,324 (Direct) |
View |
| 2022-02-10 Gift |
2023-02-22 4:23 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
127,850 | $0 | 890,324 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 5:04 pm |
N/A 2033-01-25 |
Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 5:04 pm |
N/A 2033-01-25 |
Foghorn Therapeutics Inc. | FHTX | Cavalie Fanny Chief Strategy/Bus Ops Officer |
65,000 | $0 | 65,000 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 5:03 pm |
N/A 2033-01-25 |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 5:03 pm |
N/A 2033-01-25 |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
65,000 | $0 | 65,000 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 5:03 pm |
N/A 2033-01-25 |
Foghorn Therapeutics Inc. | FHTX | LaCascia Michael Chief Legal Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 5:02 pm |
N/A 2033-01-25 |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
280,000 | $0 | 280,000 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 5:02 pm |
N/A 2033-01-25 |
Foghorn Therapeutics Inc. | FHTX | Reine Allan Chief Financial Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-10-27 Option Award |
2022-10-31 4:04 pm |
N/A 2032-10-26 |
Foghorn Therapeutics Inc. | FHTX | Lynch Thomas J. Jr. Director |
32,000 | $8.23 | 32,000 (Direct) |
View |
| 2022-09-16 Exercise |
2022-09-19 4:06 pm |
N/A 2027-05-29 |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
40,000 | $0 | 930,629 (Direct) |
View |
| 2022-09-16 Exercise |
2022-09-19 4:06 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer |
40,000 | $0.54 | 930,629 (Direct) |
View |
| 2022-09-12 Exercise |
2022-09-14 8:59 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director |
82,000 | $0.73 | 141,249 (Direct) |
View |
| 2022-09-12 Exercise |
2022-09-14 8:59 pm |
N/A 2027-11-01 |
Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director |
82,000 | $0 | 141,249 (Direct) |
View |
| 2022-09-13 Gift |
2022-09-14 8:59 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director |
47,939 | $0 | 141,249 (Direct) |
View |
Ownership(A) |
2022-09-13 8:45 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | SMITH IAN F Director |
0 | $0 | 96,396 (Direct) |
View |
Ownership(A) |
2022-09-09 7:38 pm |
N/A 2032-01-25 |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
0 | $0 | 283,107 (Direct) |
View |
Ownership(A) |
2022-09-09 7:38 pm |
N/A 2032-01-25 |
Foghorn Therapeutics Inc. | FHTX | Cavalie Fanny Chief Strategy/Bus Ops Officer |
0 | $0 | 250,169 (Direct) |
View |
| 2022-08-16 Option Award |
2022-08-18 7:09 pm |
N/A 2032-08-15 |
Foghorn Therapeutics Inc. | FHTX | PARSHALL B LYNNE Director |
32,000 | $16.34 | 32,000 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-15 6:15 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
1,858 | $3.72 | 175,673 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-15 6:15 pm |
N/A 2029-02-12 |
Foghorn Therapeutics Inc. | FHTX | Bellon Steven F. Chief Scientific Officer |
1,858 | $0 | 175,673 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-03 9:06 pm |
N/A 2032-07-31 |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2022-08-03 9:05 pm |
N/A 2031-01-27 |
Foghorn Therapeutics Inc. | FHTX | Costa Carlos Chief People Officer |
0 | $0 | 250,169 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 9:00 pm |
2023-06-21 2032-06-20 |
Foghorn Therapeutics Inc. | FHTX | Biller Scott Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 9:00 pm |
2023-06-21 2032-06-20 |
Foghorn Therapeutics Inc. | FHTX | Mendelsohn Michael Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 9:00 pm |
2023-06-21 2032-06-20 |
Foghorn Therapeutics Inc. | FHTX | Cole Douglas G. Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 9:00 pm |
2023-06-21 2032-06-20 |
Foghorn Therapeutics Inc. | FHTX | SMITH IAN F Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 8:59 pm |
2023-06-21 2032-06-20 |
Foghorn Therapeutics Inc. | FHTX | KADOCH CIGALL Director 10% Owner |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 8:59 pm |
2023-06-21 2032-06-20 |
Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 8:59 pm |
2023-06-21 2032-06-20 |
Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director |
16,000 | $0 | 16,000 (Direct) |
View |